Jul 21, 2025 08:01AM

Jul 21, 2025 08:00AM

Jul 10, 2025 04:31PM

Jul 10, 2025 04:30PM

Mar 13, 2025 08:00AM

Mar 4, 2025 01:01PM

Mar 4, 2025 01:00PM NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented

Mar 3, 2025 08:00AM

Feb 21, 2025 08:00AM

Feb 12, 2025 08:06AM

Feb 12, 2025 08:00AM

Dec 2, 2024 04:08PM

Dec 2, 2024 04:05PM

May 20, 2024 08:05AM NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Disease

Apr 29, 2024 08:01AM

Apr 29, 2024 08:00AM

Dec 28, 2023 04:05PM

Dec 27, 2023 08:01AM

Dec 27, 2023 08:00AM

Nov 14, 2023 04:48PM

Oct 26, 2023 08:00AM NKGen Biotech Presented Phase I Clinical Trial Data at the 16th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Oct 24, 2023 08:06AM

Oct 24, 2023 08:00AM

322,900 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All